A number of studies have indicated that biomarkers, such as tumor markers [20,21], vascular endothelial growth factor (VEGF) family [22,23], E-cadherin [24,25], and microRNAs [26], might be useful for predicting recurrence of gastric cancer. This evidence concerns the gene VEGFA and gastric cancer.